SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001032210-99-001139
Filing Date
1999-08-04
Accepted
1999-08-04 00:00:00
Documents
10
Period of Report
1999-07-21
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K 8-K 8024
2 SECURITIES PURCHASE AGREEMENT EX-1.1 56232
3 REGISTRATION RIGHTS AGREEMENT EX-1.2 41285
4 FUNDING AGREEMENT EX-1.3 16127
5 SUBSCRIPTION, JOINT DEVEL. & OPER. AGREEMENT EX-1.4 113547
6 CONVERTIBLE PROMISSORY NOTE EX-1.5 26223
7 LICENSE AGREEMENT DATE JULY 21, 1999 EX-1.6 101684
8 LICENSE AGREEMENT DATE JULY 21, 1999 EX-1.7 95892
9 ARTICLES OF AMENDMENT, FILED WITH THE STATE OF WA. EX-1.8 25691
10 FIRST AMENDMENT OF RIGHTS AGREEMENT JULY 21, 1999 EX-1.9 2052
  Complete submission text file 0001032210-99-001139.txt   489251
Mailing Address 1100 OLIVE WAY STE 100 SEATTLE WA 98101
Business Address 1100 OLIVE WAY STE 100 SEATTLE WA 98101 2066237612
TARGETED GENETICS CORP /WA/ (Filer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23930 | Film No.: 99677708
SIC: 2836 Biological Products, (No Diagnostic Substances)